124 research outputs found

    Customising excitation properties of polycyclic aromatic hydrocarbons by rational positional heteroatom doping: the peri-xanthenoxanthene (PXX) case

    Get PDF
    In this paper we tackle the challenge of gaining control of the photophysical properties of PAHs through a site-specific N-doping within the structural aromatic framework. By developing a simple predictive tool that identifies C(sp2)-positions that if substituted with a heteroatom would tailor the changes in the absorption and emission spectral envelopes, we predict optimal substitutional patterns for the model peri-xanthenoxanthene (PXX) PAH. Specifically, TDDFT calculations of the electron density difference between the S1 excited state and S0 ground state of PXX allowed us to identify the subtleties in the role of sites i.e., electron donating or withdrawing character on excitation. The replacement of two C(sp2)-atoms with two N-atoms, in either electron donating or withdrawing positions, shifts the electronic transitions either to low or high energy, respectively. This consequently shifts the PXX absorption spectral envelop bathochromically or hypsochromically, as demonstrated by steady-state absorption spectroscopic measurements. Within the series of synthesised N-doped PXX, we tune the optical band gap within an interval of ∼0.4 eV, in full agreement with the theoretical predictions. Relatedly, measurements show the more blueshifted the absorption/emission energies, the greater the fluorescence quantum yield value (from ∼45% to ∼75%). On the other hand, electrochemical investigations suggested that the N-pattern has a limited influence on the redox properties. Lastly, depending on the N-pattern, different supramolecular organisations could be obtained at the solid-state, with the 1,7-pattern PXX molecule forming multi-layered, graphene-like, supramolecular sheets through a combination of weak H-bonding and π–π stacking interactions. Supramolecular striped patterned sheets could also be formed with the 3,9- and 4,10-congeners when co-crystallized with a halogen-bond donor molecule

    intravoxel incoherent motion measurements in the human placenta using echo-planar imaging at 0.5

    Get PDF
    This paper presents the first in vivo measurements of intravoxel incoherent motion in the human placenta, obtained using the pulsed gradient spin echo (PGSE) sequence. The aims of this study were two-fold. The first was to provide an initial estimate of the values of the IVIM parameters in this organ, which are currently unknown. The second aim was then to use these results to optimize the sequence timings for future studies

    Muscle co-contraction patterns in robot-mediated force field learningto guide specific muscle group training

    Get PDF
    BACKGROUND: Muscle co-contraction is a strategy of increasing movement accuracy and stability employed in dealing with perturbation of movement. It is often seen in neuropathological populations. The direction of movement influences the pattern of co-contraction, but not all movements are easily achievable for populations with motor deficits. Manipulating the direction of the force instead, may be a promising rehabilitation protocol to train movement with use of a co-contraction reduction strategy. Force field learning paradigms provide a well described procedure to evoke and test muscle co-contraction. OBJECTIVE: The aim of this study was to test the muscle co-contraction pattern in a wide range of arm muscles in different force-field directions utilising a robot-assisted force field learning paradigm of motor adaptation. METHOD: 42 participants volunteered to participate in a study utilising robot-assisted motor adaptation paradigm with clockwise or counter-clockwise force field. Kinematics and surface electromyography (EMG) of eight arm muscles has been measured. RESULTS: Both muscle activation and co-contraction was earlier and stronger in flexors in clockwise condition and in extensors in the counter-clockwise condition. CONCLUSIONS: Manipulating the force field direction leads to changes in the pattern of muscle co-contraction

    Feasibility and effects of adapted cardiac rehabilitation after stroke: a prospective trial

    Get PDF
    Abstract Background Despite the cardiovascular etiology of stroke, exercise and risk factor modification programs akin to cardiac rehabilitation (CR) are not available. This study aimed to establish the feasibility of adapting a CR model for individuals with mild to moderate stroke disability. A secondary objective was to determine the program's effects on aerobic and walking capacity, and stroke risk factors. Methods A repeated measures design was used with a 3-month baseline period and 6-month adapted CR intervention (n = 43, mean ± SD age 65 ± 12 years, 30 ± 28 months post stroke). Feasibility was determined by the number of participants who completed the study, occurrence of adverse events and frequency, duration and intensity of exercise performed. To determine effectiveness of the program, outcomes measured included aerobic capacity (VO2peak, ventilatory threshold), 6-Minute Walk Test (6MWT) distance, and risk factors. Descriptive statistics characterized the classes attended and number and intensity of exercise sessions. Paired t-tests, one-factor repeated measures analyses of variance contrasts and chi-square analyses were used to compare changes over time. Results Two participants withdrew during the baseline period. Of the remaining 41 participants who commenced the program, 38 (93%) completed all aspects. No serious adverse effects occurred. Post-intervention, VO2peak improved relative to the stable baseline period (P = 0.046) and the increase in ventilatory threshold approached significance (P = 0.062). Conclusions CR is feasible after stroke and may be adapted to accommodate for those with a range of post-stroke disability. It is effective in increasing aerobic capacity. CR may be an untapped opportunity for stroke survivors to access programs of exercise and risk factor modification to lower future event risk. Trial registration ClinicalTrials.gov registration number: NCT0106749
    • …
    corecore